Blinatumomab in Ph+ B-ALL: present and perspectives.

Oncotarget 2017 Nov 25;8(55):93309-93310. Epub 2017 Oct 25.

Cristina Papayannidis: Institute of Hematology and Medical Oncology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, Bologna University School of Medicine, Bologna, Italy.

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.22071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706793PMC
November 2017
7 Reads

Publication Analysis

Top Keywords

ph+ b-all
4
b-all perspectives
4
blinatumomab ph+
4
perspectives
1
b-all
1
blinatumomab
1

Similar Publications